Attanasio, Ermanno; Russo, Pierluigi; Carunchio, Gabriella - In: PharmacoEconomics 19 (2001) 1, pp. 57-68
Background: In a recent clinical trial, dermatan sulfate was found to be more effective than unfractionated heparin (UFH), but equally well tolerated, for the prevention of deep vein thrombosis (DVT) after major surgery for cancer. Objective: To perform a cost-effectiveness analysis of dermatan...